These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2751731

  • 1. Cardiovascular effects of 1-(3,4-dimethoxyphenyl)-2-(4-diphenylmethylpiperazinyl) ethanol and possible mechanisms involved.
    Kushiku K, Ohba M, Araki T, Mikagi T, Katsuragi T, Furukawa T.
    Arzneimittelforschung; 1989 Apr; 39(4):458-63. PubMed ID: 2751731
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular actions of buflomedil and possible mechanisms involved.
    Kushiku K, Ohba M, Mikagi T, Nuki S, Araki Y, Furukawa T.
    Arzneimittelforschung; 1989 Jun; 39(6):670-7. PubMed ID: 2775333
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M, Takasuna K, Yamashita N, Tamura K.
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [Abstract] [Full Text] [Related]

  • 4. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
    Kushiku K, Morishita H, Furukawa T, Kitagawa H, Ueno K, Kitagawa H, Kohei H.
    Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
    [Abstract] [Full Text] [Related]

  • 5. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system].
    Nakamura T, Miura Y, Aihara K, Satoh H, Goto K, Tsumagari T.
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):79-92. PubMed ID: 6137441
    [Abstract] [Full Text] [Related]

  • 6. [Effects of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol (ifenprodil) on the cardiovascular system in vivo].
    Mizusawa H, Sakakibara E.
    Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):597-608. PubMed ID: 1238330
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I, Lorrain J, Di Paola ED, Lhoste F, Payen B, Dennis T, Scatton B.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [Abstract] [Full Text] [Related]

  • 8. Comparison of calcium channel inhibitors on vagal heart rate responses elicited by arterial baroreceptor reflexes in anesthetized dogs.
    Taylor DG, Kowalski TE.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):491-9. PubMed ID: 6694122
    [Abstract] [Full Text] [Related]

  • 9. Functional role of alpha-calcitonin gene-related peptide in the regulation of the cardiovascular system.
    Shen YT, Pittman TJ, Buie PS, Bolduc DL, Kane SA, Koblan KS, Gould RJ, Lynch JJ.
    J Pharmacol Exp Ther; 2001 Aug; 298(2):551-8. PubMed ID: 11454916
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of brovincamine and possible mechanisms involved.
    Kushiku K, Katsuragi T, Mori R, Morishita H, Furukawa T.
    Clin Exp Pharmacol Physiol; 1985 Aug; 12(2):121-30. PubMed ID: 4006317
    [Abstract] [Full Text] [Related]

  • 11. [Effects of the anti-ulcer drug SU-88 on the gastric blood flow and the cardiovascular system (author's transl)].
    Saziki R, Arai I, Isobe Y, Aihara H.
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):193-202. PubMed ID: 7084818
    [Abstract] [Full Text] [Related]

  • 12. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
    Panzenbeck MJ, Hintze TH, Kaley G.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
    [Abstract] [Full Text] [Related]

  • 13. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
    Imamoto T, Tanabe M, Shimamoto N, Kawazoe K, Hirata M.
    Arzneimittelforschung; 1984 Mar; 34(2):161-9. PubMed ID: 6539108
    [Abstract] [Full Text] [Related]

  • 14. Presynaptic dopamine receptor stimulation in the cardiovascular actions of lergotrile.
    Barrett RJ, Lokhandwala MF.
    J Pharmacol Exp Ther; 1981 Jun; 217(3):660-5. PubMed ID: 6112262
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular properties of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N- methylbenzamide.
    Hirohashi M, Takasuna K, Asano M, Ryokawa Y, Tamura K.
    Arzneimittelforschung; 1993 May; 43(5):578-83. PubMed ID: 8329003
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E, Murai T, Ishizaka Y, Sanai K.
    Arzneimittelforschung; 1984 May; 34(11A):1641-51. PubMed ID: 6152157
    [Abstract] [Full Text] [Related]

  • 17. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S, Watanabe K, Kawamura K, Mori T, Tani T, Toba Y, Sasabe H, Nakagiri N, Hongoh O, Fujita S.
    Arzneimittelforschung; 1985 May; 35(7A):1163-72. PubMed ID: 3000392
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M, Schiavi P, Vincent M, Schmitt H.
    J Cardiovasc Pharmacol; 1984 May; 6(6):1076-82. PubMed ID: 6084763
    [Abstract] [Full Text] [Related]

  • 19. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T, Yoshino K, Kanazawa T, Ito K, Nose T.
    Arzneimittelforschung; 1982 May; 32(9):1037-42. PubMed ID: 6890822
    [Abstract] [Full Text] [Related]

  • 20. [Effects of oxybutynin on the cardiovascular system in dogs].
    Misawa M, Hosokawa T, Kamei J, Yanaura S, Fujii Y, Watanabe K, Uehara M, Kasama T.
    Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):395-406. PubMed ID: 6510843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.